This conclusion aligns with previous studies, such as the inhibition of NLRP3 inflammasome, coincident with the downregulation of MMP2 expression in the lesion site of abdominal aortic aneurysm (AAA), and the prevention of elastin degradation [32]. The gene discussed is NLRP3; the disease is abdominal aortic aneurysm.